Latest Industry Insights
Industry Insight
Bringing Behavioral Assays to the Bench
How do you reliably quantify behavior? Zantiks CEO Dr. Bill Budenberg Explains
Industry Insight
Novel Neuromuscular Junction Model Benefits Drug Discovery
The first functional stem-cell derived neuromuscular junction model has recently been licensed, which could help the quest to develop new drugs to treat associated neurodegenerative diseases. We caught up with James Hickman, CSO, Hesperos, to learn more about the model, and some of the benefits it brings.
Industry Insight
Newly Discovered Biomarker Could Help Diagnose Hearing Loss Earlier
In collaboration with UConn, Sensorion have identified the first potential biomarker for noise-induced hearing loss, findings which were recently presented at the 53rd American Neurotology Society Annual Spring Meeting.
Industry Insight
Revolutionizing the World of Pipetting
Necessity is the mother of invention, and nowhere is this more clearly demonstrated than in the laboratory. We caught up with Alex Studer, VP of Marketing and Innovation at INTEGRA Biosciences, to discuss the company’s aim to transform the world of pipetting.
Industry Insight
Building in Purity
Laboratories rely on the constant provision of high quality water for a variety of purposes, from glass washing to reagent preparation and instrumental analysis. It is all too easy to take this valuable commodity for granted yet, behind the scenes, a great deal of thought goes into designing a facility that reliably and cost-effectively provides water of the required quality on a round the clock basis.
Industry Insight
Carrying the Torch for Scientific Glassblowing
Despite the important role glass plays in science, the skill to develop the glassware is in decline. Scientific glassblowing has now been classed as an endangered craft by The Radcliffe Trust.
Industry Insight
MicroTissue: Transforming Drug Discovery
We spoke to Ping Yeh, CEO of StemoniX, to learn more about the company and their mission. With an aim to accelerate and optimize drug discovery and development, StemoniX creates ‘ready-to-use’ microtissue plates that mimic the native organ tissue.
Industry Insight
Preclinical Alpha Synuclein Model Developed
Horizon and the Michael J Fox foundation have teamed up to generate a preclinical animal model of parkinson's disease.
Industry Insight
The Attraction of Dry-Magnet MRI Systems
David Taylor, CEO, MR Solutions talks to us about their development of dry-magnet MRI systems
Industry Insight
Tackling the Opioid Crisis: Genetic testing to identify addiction risk
Dr Keri Donaldson, CEO and founder of predictive health intelligence company Prescient Medicine, tells us about the role that genetic testing could play in tackling the opioid crisis.
Advertisement